The Food and Drug Administration plans to create a new office to improve the review of new medicines — one that will develop a standardized approach to using personalized medicine, digital data, and patients’ own reports, according to Commissioner Scott Gottlieb.
{iframe}https://www.statnews.com/2019/01/07/fda-plans-to-create-a-new-office-to-leverage-cutting-edge-science/{/iframe}